NCT06337812

Brief Summary

The study team is studying how increasing dietary fiber, specifically through adding potato starch to participant's diet, may impact the species of bacteria in participant's gut microbiome. The study team also wants to understand if adding potato starch to participant's diet helps these bacteria make more short chain fatty acids, a byproduct the team thinks may benefit participant's health.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
6mo left

Started Apr 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Apr 2024Dec 2026

First Submitted

Initial submission to the registry

March 22, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 29, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

July 24, 2025

Status Verified

July 1, 2025

Enrollment Period

2.2 years

First QC Date

March 22, 2024

Last Update Submit

July 22, 2025

Conditions

Keywords

Fiber SupplementationPotato StarchGut microbiomeResistant starch

Outcome Measures

Primary Outcomes (6)

  • Changes in Short Chain Fatty Acid (SCFA) butyrate levels - stool

    Stool will be analyzed.

    Baseline, approximately 4 weeks

  • Changes in Short Chain Fatty Acid (SCFA) butyrate levels - plasma

    Plasma samples will be analyzed.

    Baseline, approximately 4 weeks

  • Changes in propionate levels - stool

    Stool will be analyzed.

    Baseline, approximately 4 weeks

  • Changes in propionate levels- plasma

    Plasma samples will be analyzed.

    Baseline, approximately 4 weeks

  • Changes in acetate levels- stool

    Stool will be analyzed.

    Baseline, approximately 4 weeks

  • Changes in acetate levels- plasma

    Plasma samples will be analyzed.

    Baseline, approximately 4 weeks

Study Arms (1)

Potato starch supplement

EXPERIMENTAL

Participants will take the supplement for approximately 4 weeks.

Dietary Supplement: Potato Starch

Interventions

Potato StarchDIETARY_SUPPLEMENT

Participants will consume 10 grams (1/2 a packet) of Bob's Red Mill Potato Starch twice a day for the first 7 days and then increase to 20 grams (full packet) of potato starch for approximately 3 weeks. Potato starch can be mixed into cold food or beverage for consumption. In addition, participants will have evaluations and provide blood and stool samples during the study.

Potato starch supplement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A confirmed clinical diagnosis of stable HFpEF on maximally tolerated Heart Failure (HF) medical regimen (without changes in dosage in the prior month)
  • Left ventricular ejection fraction of \>50% documented in the prior 12 months
  • A confirmed clinical diagnosis of Type II diabetes (T2DM) with glycated hemoglobin \<10% without changes in medical regimen in the past month.

You may not qualify if:

  • Current usage of pre- or probiotic usage
  • Antibiotic usage in the past 6 months
  • Current participation in another interventional clinical trial
  • History of potato allergy or potato starch allergy, inflammatory bowel syndrome, inflammatory bowel disease, bowel resection, Roux-en-Y gastric bypass surgery, celiac disease, Crohn's disease, or colorectal cancer
  • Hypoglycemic episode with blood glucose 70 milligrams per deciliter (mg/dL) within the last month
  • Stage IV-V chronic kidney disease
  • Pregnancy (self-reported)
  • Comorbidity limiting survival to \< 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

RECRUITING

Study Officials

  • Scott Hummel, MD, MS

    University of Michigan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hayley Billingsley, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 22, 2024

First Posted

March 29, 2024

Study Start

April 1, 2024

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 24, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations